

Fundamental dimension Equity attribute | QRVOPeer $114.170.00% Cap $10.07BP/E 26.2x QuantScore53/100 | ADIPeer $391.07▲+1.38% Cap $189.5BP/E 46.2x QuantScore67/100 | CRUSLeader $112.32▲+1.66% Cap $5.63BP/E 13.3x QuantScore68/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
74/100 |
68/100 |
56/100 |
Valuation Multiples, PEG & DCF upside | 69/100 | 42/100 | 99/100 |
Health Piotroski, Altman Z, leverage & liquidity | 71/100 | 77/100 | 100/100 |
Growth Revenue / earnings growth & margins | 34/100 | 64/100 | 31/100 |
Sentiment Analyst ratings, targets & revisions | 20/100 | 85/100 | 52/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 26.2x | 46.2x | 13.3x |
Forward P/E (next FY) | 14.9x | 30.4x | 13.3x |
EV / EBITDA (TTM) | 13.2x | 28.0x | 9.0x |
Price / Sales | 2.8x | 13.7x | 2.7x |
Price / Free Cash Flow | 15.5x | 38.4x | 9.8x |
PEG ratio | 0.07 | 0.40 | 0.48 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 9 / 9 | 8 / 9 | 8 / 9 |
Altman Z-Score | 3.74 (Safe) | 8.67 (Safe) | 11.27 (Safe) |
Total debt / equity | 0.45 | 0.27 | 0.08 |
Quick ratio | 2.7x | 0.9x | 6.2x |
Interest coverage | 6.8x | 14.1x | 471.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -1.1% | +16.9% | +5.3% |
Net income growth YoY | +509.5% | +38.7% | +25.0% |
Gross margin (TTM) | 48.2% | 65.8% | 52.8% |
Operating margin (FY) | 11.2% | 26.6% | 23.0% |
FCF margin (FY) | 18.5% | 38.8% | 31.9% |
5. Trailing price performancePrice change over period |
1M return | -1.9% | +2.2% | -5.5% |
3M return | +32.0% | +5.2% | -15.9% |
6M return | +30.0% | -2.1% | -35.5% |
Year to date | +35.1% | +44.2% | -5.2% |
1Y return | +25.9% | +64.3% | -14.0% |
3Y return | +28.5% | +137.1% | +67.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $53.00 -53.6% premium | $172.35 -55.9% premium | $156.92 +39.7% upside |
Wall Street consensus target | $108.00 -5.4% · range $96.00–$120.00 | $480.24 +22.8% · range $405.00–$675.00 | $160.00 +42.5% · range $130.00–$190.00 |
Consensus stance | 29% Buy67% Hold5% Sell | 83% Buy17% Hold-0% Sell | 64% Buy23% Hold14% Sell |